NCT06390371Active, not recruiting
Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)
Spotlight AQ Randomized Controlled Trial of the Spotlight AQ Survey Platform to Evaluate Its' Efficacy and Applicability in a Clinic Setting.
Source: ClinicalTrials.gov · Last updated 9 Jul 2026
Brief summary (registry, in English)
The goal of this clinical trial is to compare the Spotlight AQ survey platform to the standard of care (SOC) pre-clinic assessment in adolescents \& young adults (16-25 years old) with Type 1 Diabetes (T1D). The main questions it aims to answer are: * Does using the Spotlight AQ survey in clinic decrease the A1c in the people who use it? * Do patients and healthcare providers like using the spotlight AQ survey? Participants will use the Spotlight AQ survey before coming in to two standard of care T1D clinic visits Participants will fill out surveys describing how they feel about using the Spotlight AQ survey. Some participants may be asked to do an interview to talk about how they feel about the Spotlight AQ survey.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 15 Apr 2024
- Start date
- 18 May 2024
- Primary completion date
- 18 May 2026
- Lead sponsor
- Children's Mercy Hospital Kansas City
- Diseases
- Type 1 diabetes
- NCT number
- NCT06390371
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 18 May 2024 to the primary completion date, 18 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Mental illness that could seriously reduce their ability to participate in the study
Age
- \<16 years old or \>25 years old
Other
- Lack of capacity
- In another T1D intervention study
Who the study is looking for
- 16-25 years old
- Patients diagnosed with T1D for at least 6 months
- On any diabetes treatment
- Using a Continuous Glucose Monitor (CGM)
- Willing/ able to use Spotlight AQ tool
- Able to give verbal assent
- Patients \& parents/caregiver speak English/ Spanish fluently
- Patients in the Children's Mercy Kansas City Hospital or Boston Children's Hospital network
Age in the registry: 16 years to 25 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Children's Mercy Coordinator of this site? Confirm its status | Kansas City | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.